The epidemiological trends and impact of resistance on the outcome of neonatal omphalitis: 12 years experience in a medical center

Clinical Neonatology

Volumn 13, Issue 2, 2006, Pages 55-59

  Chang, Jenn Tzong ^a   Lin, Shu Ming ^b   Wang, Hsiao Ping ^a   Chen, Ying Yao ^a   Hsieh, Kai Sheng ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Pingtung Hospital   (Taiwan)

Author keywords

Escherichia coli; Newborn; Omphalitis; Resistance; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIAL INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN INFECTION; OMPHALITIS; STAPHYLOCOCCUS AUREUS; TREATMENT PLANNING; TREND STUDY; UMBILICAL CORD COMPLICATION;

EID: 34247485453     PISSN: 13813390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 205;5:481-93.
2. Laxminarayan R. Battling resistance to antibiotics and pesticides: an economic approach. Washington, DC: Resources for the Future Press, 2003.
3. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003;37:230-7.
4. Sawardekar KP. Changing spectrum of neonatal omphalitis. Pediatr Infect Dis J 2004;23:22-6.
5. Stoll BJ, Kliegman RM. The umbilicus. Behrman RE, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics. 17th ed. Philadelphia: WB Saunders, 2004;609.
6. Pomeranz A. Anomalies, abnormalities, and care of the umbilicus. Pediatr Clin North Am 2004; 51:819-27.
7. Burchett SK. Infections. Cloherty JP, Eichenwald EC, Stark AR (eds). Manual of Neonatal Care. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2004;310.
8. Chiou CC, Does penicillin remain the drug of choice for pneumococcal pneumonia in view of emerging in vitro resistance? Clin Infect Dis 2006;42:234-7.
9. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32 Suppl 2:S114-132.
10. Schito GC. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect 2006;12 Suppl 1:3-8.
11. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275-86.
12. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123-7.